CF PharmTech (02652) Reports Share Repurchase and Updated Issued Shares

Bulletin Express02-25 19:00

CF PharmTech, Inc. (02652) disclosed a repurchase of 33,000 H shares on 25 February 2026. The highest repurchase price reached HKD 37.90, and the lowest repurchase price was HKD 36.64, for an aggregate consideration of HKD 1.23 million.

After the transaction, the number of issued shares excluding treasury shares stood at 301.80 million, while treasury shares increased to 0.42 million, bringing the total share count to 302.22 million. The financial filing shows that the repurchased shares are held as treasury shares. The adjustment in treasury shares accounts for approximately 0.0109% of the existing issued shares (excluding treasury shares) prior to the repurchase.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment